Cryptococcal meningoradiculitis: An atypical presentation after initiation of antiretroviral therapy

Journal of the Medical Association of Thailand

Volumn 90, Issue SUPPL 2, 2007, Pages 85-88

  Jongwutiwes, Ubonvan ^a   Malathum, Kumthorn ^b   Sungkanuparph, Somnuek ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cryptococcus; HIV; Immune reconstitution inflammatory syndrome; Meningoradiculitis

Indexed keywords

AMPHOTERICIN B; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; CEFTRIAXONE; CIPROFLOXACIN; LAMIVUDINE; NEVIRAPINE; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CRYPTOCOCCAL MENINGITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOPHYSIOLOGY; RADICULOPATHY;

ADULT; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CEFTRIAXONE; CIPROFLOXACIN; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; MENINGITIS, CRYPTOCOCCAL; NEVIRAPINE; RADICULOPATHY; STAVUDINE;

EID: 61549087793     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-60.
2. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18: 1615-27.
3. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002; 35: e128-33.
4. Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005; 19: 1043-9.
5. Shelburne SA III, Darcourt J, White AC Jr, Greenberg SB, Hamill RJ, Atmar RL, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 1049-52.
6. Chariyalertsak S, Sirisanthana T, Saengwonloey O, Nelson KE. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: regional variation and temporal trends. Clin Infect Dis 2001; 32: 955-62.
7. Deus-Silva L, Costa AE, Bevilacqua JM, Assis DB, Ferraz CA Jr, Oliveira AC, et al. Meningoradiculitis due to Cryptococcus neofermans in an immunocompetent patient. Arq Neuropsiquiatr 2004; 62: 147-9.
8. Dichgans M, Seelos K, Wick M, Pfister HW. Meningoradiculitis with severe tetraparesis, and unusual manifestation of infection due to Cryptococcus neoformans variety gattii. Clin Infect Dis 1998; 26: 524-5.
9. Lai PH, Wang JS, Chen WL, Pan HB, Yang CF. Intramedullary spinal cryptococcoma: a case report. J Formos Med Assoc 2001; 100: 776-8.
10. Stein SC, Corrado ML, Friedlander M, Farmer P. Chronic mycotic meningitis with spinal involvement (arachnoiditis): a report of five cases. Ann Neurol 1982; 11: 519-24.
11. Su MC, Ho WL, Chen JH. Intramedullary cryptococcal granuloma of spinal cord: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1994; 53: 58-61.
12. van Dellen JR, Buchanan N. Intrathecal cryptococcal lesion of the cauda equina successfully treated with intrathecal amphotericin B: a case report. S Afr Med J 1980; 58: 137-8.
13. Woods ML, MacGinley R, Eisen DP, Allworth AM. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 1998; 12: 1491-4.
14. Broom J, Woods M, Allworth A. Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningitis: case report and a review of immune reconstitutionassociated cryptococcal infections. Scand J Infect Dis 2006; 38: 219-21.
15. Fournier S, Rabian C, Alberti C, Carmagnat MV, Garin JF, Charron D, et al. Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon-gamma production in the presence of Toxoplasma gondii antigens. J Infect Dis 2001; 183: 1586-91.
16. Hsieh SM, Hung CC, Pan SC, Wang JT, Tsai HC, Chen MY, et al. Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment by determination of CD69 expression on T cells after tuberculin stimulation. J Acquir Immune Defic Syndr 2000; 25: 212-20.
17. Franco JM, Leon-Leal JA, Leal M, Cano-Rodriguez A, Pineda JA, Macias J, et al. CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol 2000; 119: 493-8.
18. Cattelan AM, Trevenzoli M, Sasset L, Lanzafame M, Marchioro U, Meneghetti F. Multiple cerebral cryptococcomas associated with immune reconstitution in HIV-1 infection. AIDS 2004; 18: 349-51.
19. Trevenzoli M, Cattelan AM, Rea F, Sasset L, Semisa M, Lanzafame M, et al. Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. J Infect 2002; 45: 173-9.
20. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133: 447-54.
21. Lederman MM, Valdez H. Immune restoration with antiretroviral therapies: implications for clinical management. JAMA 2000; 284: 223-8.